Global Vonoprazan Fumarate Market Growth 2026-2032
The global Vonoprazan Fumarate market size is predicted to grow from US$ 781 million in 2025 to US$ 1451 million in 2032; it is expected to grow at a CAGR of 9.4% from 2026 to 2032.
Vonoprazan fumarate is a novel potassium-competitive acid blocker (P-CAB) that selectively inhibits the potassium-binding site of the gastric parietal cell H?/K?-ATPase, providing rapid and sustained gastric acid suppression. It is primarily indicated for the treatment of gastroesophageal reflux disease, peptic ulcers, and Helicobacter pylori-related conditions, offering advantages such as fast onset, prolonged action, adaptability to interpatient gastric acid variation, and independence from acidic activation. Its production relies on the synthesis of the active pharmaceutical ingredient (API) using fine chemicals and intermediates, along with excipients and capsule shell suppliers, as well as pharmaceutical manufacturing equipment and analytical instrument providers, forming a complete support chain for research, production, and commercialization. In 2024, the global sales volume of vonoprazan fumarate reached 21.10 million boxes, with an average unit price of USD 37 per box.
United States market for Vonoprazan Fumarate is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Vonoprazan Fumarate is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Vonoprazan Fumarate is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Vonoprazan Fumarate players cover Takeda Pharmaceuticals, Shandong New Era Pharmaceutical, Chongqing Huasen Pharmaceutical, Sichuan Kelun Pharmaceutical, Yangzijiang Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
This Insight Report provides a comprehensive analysis of the global Vonoprazan Fumarate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vonoprazan Fumarate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vonoprazan Fumarate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vonoprazan Fumarate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vonoprazan Fumarate.
This report presents a comprehensive overview, market shares, and growth opportunities of Vonoprazan Fumarate market by product type, application, key manufacturers and key regions and countries.
Vonoprazan fumarate is a novel potassium-competitive acid blocker (P-CAB) that selectively inhibits the potassium-binding site of the gastric parietal cell H?/K?-ATPase, providing rapid and sustained gastric acid suppression. It is primarily indicated for the treatment of gastroesophageal reflux disease, peptic ulcers, and Helicobacter pylori-related conditions, offering advantages such as fast onset, prolonged action, adaptability to interpatient gastric acid variation, and independence from acidic activation. Its production relies on the synthesis of the active pharmaceutical ingredient (API) using fine chemicals and intermediates, along with excipients and capsule shell suppliers, as well as pharmaceutical manufacturing equipment and analytical instrument providers, forming a complete support chain for research, production, and commercialization. In 2024, the global sales volume of vonoprazan fumarate reached 21.10 million boxes, with an average unit price of USD 37 per box.
United States market for Vonoprazan Fumarate is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Vonoprazan Fumarate is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Vonoprazan Fumarate is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Vonoprazan Fumarate players cover Takeda Pharmaceuticals, Shandong New Era Pharmaceutical, Chongqing Huasen Pharmaceutical, Sichuan Kelun Pharmaceutical, Yangzijiang Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Vonoprazan Fumarate Industry Forecast” looks at past sales and reviews total world Vonoprazan Fumarate sales in 2025, providing a comprehensive analysis by region and market sector of projected Vonoprazan Fumarate sales for 2026 through 2032. With Vonoprazan Fumarate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vonoprazan Fumarate industry.This Insight Report provides a comprehensive analysis of the global Vonoprazan Fumarate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vonoprazan Fumarate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vonoprazan Fumarate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vonoprazan Fumarate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vonoprazan Fumarate.
This report presents a comprehensive overview, market shares, and growth opportunities of Vonoprazan Fumarate market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- 10mg Tablets
- 20mg Tablets
Segmentation by Application:
- Hospital and Clinic
- Retail Pharmacies
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Takeda Pharmaceuticals
- Shandong New Era Pharmaceutical
- Chongqing Huasen Pharmaceutical
- Sichuan Kelun Pharmaceutical
- Yangzijiang Pharmaceutical
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Vonoprazan Fumarate market?
- What factors are driving Vonoprazan Fumarate market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Vonoprazan Fumarate market opportunities vary by end market size?
- How does Vonoprazan Fumarate break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vonoprazan Fumarate Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Vonoprazan Fumarate by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Vonoprazan Fumarate by Country/Region, 2021, 2025 & 2032
2.2 Vonoprazan Fumarate Segment by Type
2.2.1 10mg Tablets
2.2.2 20mg Tablets
2.2.3 Vonoprazan Fumarate Sales by Type
2.2.3.1 Global Vonoprazan Fumarate Sales Market Share by Type (2021-2026)
2.2.3.2 Global Vonoprazan Fumarate Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Vonoprazan Fumarate Sale Price by Type (2021-2026)
2.3 Vonoprazan Fumarate Segment by Application
2.3.1 Hospital and Clinic
2.3.2 Retail Pharmacies
2.3.3 Other
2.3.4 Vonoprazan Fumarate Sales by Application
2.3.4.1 Global Vonoprazan Fumarate Sale Market Share by Application (2021-2026)
2.3.4.2 Global Vonoprazan Fumarate Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Vonoprazan Fumarate Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Vonoprazan Fumarate Breakdown Data by Company
3.1.1 Global Vonoprazan Fumarate Annual Sales by Company (2021-2026)
3.1.2 Global Vonoprazan Fumarate Sales Market Share by Company (2021-2026)
3.2 Global Vonoprazan Fumarate Annual Revenue by Company (2021-2026)
3.2.1 Global Vonoprazan Fumarate Revenue by Company (2021-2026)
3.2.2 Global Vonoprazan Fumarate Revenue Market Share by Company (2021-2026)
3.3 Global Vonoprazan Fumarate Sale Price by Company
3.4 Key Manufacturers Vonoprazan Fumarate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vonoprazan Fumarate Product Location Distribution
3.4.2 Players Vonoprazan Fumarate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VONOPRAZAN FUMARATE BY GEOGRAPHIC REGION
4.1 World Historic Vonoprazan Fumarate Market Size by Geographic Region (2021-2026)
4.1.1 Global Vonoprazan Fumarate Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Vonoprazan Fumarate Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Vonoprazan Fumarate Market Size by Country/Region (2021-2026)
4.2.1 Global Vonoprazan Fumarate Annual Sales by Country/Region (2021-2026)
4.2.2 Global Vonoprazan Fumarate Annual Revenue by Country/Region (2021-2026)
4.3 Americas Vonoprazan Fumarate Sales Growth
4.4 APAC Vonoprazan Fumarate Sales Growth
4.5 Europe Vonoprazan Fumarate Sales Growth
4.6 Middle East & Africa Vonoprazan Fumarate Sales Growth
5 AMERICAS
5.1 Americas Vonoprazan Fumarate Sales by Country
5.1.1 Americas Vonoprazan Fumarate Sales by Country (2021-2026)
5.1.2 Americas Vonoprazan Fumarate Revenue by Country (2021-2026)
5.2 Americas Vonoprazan Fumarate Sales by Type (2021-2026)
5.3 Americas Vonoprazan Fumarate Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vonoprazan Fumarate Sales by Region
6.1.1 APAC Vonoprazan Fumarate Sales by Region (2021-2026)
6.1.2 APAC Vonoprazan Fumarate Revenue by Region (2021-2026)
6.2 APAC Vonoprazan Fumarate Sales by Type (2021-2026)
6.3 APAC Vonoprazan Fumarate Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vonoprazan Fumarate by Country
7.1.1 Europe Vonoprazan Fumarate Sales by Country (2021-2026)
7.1.2 Europe Vonoprazan Fumarate Revenue by Country (2021-2026)
7.2 Europe Vonoprazan Fumarate Sales by Type (2021-2026)
7.3 Europe Vonoprazan Fumarate Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vonoprazan Fumarate by Country
8.1.1 Middle East & Africa Vonoprazan Fumarate Sales by Country (2021-2026)
8.1.2 Middle East & Africa Vonoprazan Fumarate Revenue by Country (2021-2026)
8.2 Middle East & Africa Vonoprazan Fumarate Sales by Type (2021-2026)
8.3 Middle East & Africa Vonoprazan Fumarate Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vonoprazan Fumarate
10.3 Manufacturing Process Analysis of Vonoprazan Fumarate
10.4 Industry Chain Structure of Vonoprazan Fumarate
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vonoprazan Fumarate Distributors
11.3 Vonoprazan Fumarate Customer
12 WORLD FORECAST REVIEW FOR VONOPRAZAN FUMARATE BY GEOGRAPHIC REGION
12.1 Global Vonoprazan Fumarate Market Size Forecast by Region
12.1.1 Global Vonoprazan Fumarate Forecast by Region (2027-2032)
12.1.2 Global Vonoprazan Fumarate Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Vonoprazan Fumarate Forecast by Type (2027-2032)
12.7 Global Vonoprazan Fumarate Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Takeda Pharmaceuticals
13.1.1 Takeda Pharmaceuticals Company Information
13.1.2 Takeda Pharmaceuticals Vonoprazan Fumarate Product Portfolios and Specifications
13.1.3 Takeda Pharmaceuticals Vonoprazan Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Takeda Pharmaceuticals Main Business Overview
13.1.5 Takeda Pharmaceuticals Latest Developments
13.2 Shandong New Era Pharmaceutical
13.2.1 Shandong New Era Pharmaceutical Company Information
13.2.2 Shandong New Era Pharmaceutical Vonoprazan Fumarate Product Portfolios and Specifications
13.2.3 Shandong New Era Pharmaceutical Vonoprazan Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Shandong New Era Pharmaceutical Main Business Overview
13.2.5 Shandong New Era Pharmaceutical Latest Developments
13.3 Chongqing Huasen Pharmaceutical
13.3.1 Chongqing Huasen Pharmaceutical Company Information
13.3.2 Chongqing Huasen Pharmaceutical Vonoprazan Fumarate Product Portfolios and Specifications
13.3.3 Chongqing Huasen Pharmaceutical Vonoprazan Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Chongqing Huasen Pharmaceutical Main Business Overview
13.3.5 Chongqing Huasen Pharmaceutical Latest Developments
13.4 Sichuan Kelun Pharmaceutical
13.4.1 Sichuan Kelun Pharmaceutical Company Information
13.4.2 Sichuan Kelun Pharmaceutical Vonoprazan Fumarate Product Portfolios and Specifications
13.4.3 Sichuan Kelun Pharmaceutical Vonoprazan Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sichuan Kelun Pharmaceutical Main Business Overview
13.4.5 Sichuan Kelun Pharmaceutical Latest Developments
13.5 Yangzijiang Pharmaceutical
13.5.1 Yangzijiang Pharmaceutical Company Information
13.5.2 Yangzijiang Pharmaceutical Vonoprazan Fumarate Product Portfolios and Specifications
13.5.3 Yangzijiang Pharmaceutical Vonoprazan Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Yangzijiang Pharmaceutical Main Business Overview
13.5.5 Yangzijiang Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vonoprazan Fumarate Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Vonoprazan Fumarate by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Vonoprazan Fumarate by Country/Region, 2021, 2025 & 2032
2.2 Vonoprazan Fumarate Segment by Type
2.2.1 10mg Tablets
2.2.2 20mg Tablets
2.2.3 Vonoprazan Fumarate Sales by Type
2.2.3.1 Global Vonoprazan Fumarate Sales Market Share by Type (2021-2026)
2.2.3.2 Global Vonoprazan Fumarate Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Vonoprazan Fumarate Sale Price by Type (2021-2026)
2.3 Vonoprazan Fumarate Segment by Application
2.3.1 Hospital and Clinic
2.3.2 Retail Pharmacies
2.3.3 Other
2.3.4 Vonoprazan Fumarate Sales by Application
2.3.4.1 Global Vonoprazan Fumarate Sale Market Share by Application (2021-2026)
2.3.4.2 Global Vonoprazan Fumarate Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Vonoprazan Fumarate Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Vonoprazan Fumarate Breakdown Data by Company
3.1.1 Global Vonoprazan Fumarate Annual Sales by Company (2021-2026)
3.1.2 Global Vonoprazan Fumarate Sales Market Share by Company (2021-2026)
3.2 Global Vonoprazan Fumarate Annual Revenue by Company (2021-2026)
3.2.1 Global Vonoprazan Fumarate Revenue by Company (2021-2026)
3.2.2 Global Vonoprazan Fumarate Revenue Market Share by Company (2021-2026)
3.3 Global Vonoprazan Fumarate Sale Price by Company
3.4 Key Manufacturers Vonoprazan Fumarate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vonoprazan Fumarate Product Location Distribution
3.4.2 Players Vonoprazan Fumarate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VONOPRAZAN FUMARATE BY GEOGRAPHIC REGION
4.1 World Historic Vonoprazan Fumarate Market Size by Geographic Region (2021-2026)
4.1.1 Global Vonoprazan Fumarate Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Vonoprazan Fumarate Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Vonoprazan Fumarate Market Size by Country/Region (2021-2026)
4.2.1 Global Vonoprazan Fumarate Annual Sales by Country/Region (2021-2026)
4.2.2 Global Vonoprazan Fumarate Annual Revenue by Country/Region (2021-2026)
4.3 Americas Vonoprazan Fumarate Sales Growth
4.4 APAC Vonoprazan Fumarate Sales Growth
4.5 Europe Vonoprazan Fumarate Sales Growth
4.6 Middle East & Africa Vonoprazan Fumarate Sales Growth
5 AMERICAS
5.1 Americas Vonoprazan Fumarate Sales by Country
5.1.1 Americas Vonoprazan Fumarate Sales by Country (2021-2026)
5.1.2 Americas Vonoprazan Fumarate Revenue by Country (2021-2026)
5.2 Americas Vonoprazan Fumarate Sales by Type (2021-2026)
5.3 Americas Vonoprazan Fumarate Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vonoprazan Fumarate Sales by Region
6.1.1 APAC Vonoprazan Fumarate Sales by Region (2021-2026)
6.1.2 APAC Vonoprazan Fumarate Revenue by Region (2021-2026)
6.2 APAC Vonoprazan Fumarate Sales by Type (2021-2026)
6.3 APAC Vonoprazan Fumarate Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vonoprazan Fumarate by Country
7.1.1 Europe Vonoprazan Fumarate Sales by Country (2021-2026)
7.1.2 Europe Vonoprazan Fumarate Revenue by Country (2021-2026)
7.2 Europe Vonoprazan Fumarate Sales by Type (2021-2026)
7.3 Europe Vonoprazan Fumarate Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vonoprazan Fumarate by Country
8.1.1 Middle East & Africa Vonoprazan Fumarate Sales by Country (2021-2026)
8.1.2 Middle East & Africa Vonoprazan Fumarate Revenue by Country (2021-2026)
8.2 Middle East & Africa Vonoprazan Fumarate Sales by Type (2021-2026)
8.3 Middle East & Africa Vonoprazan Fumarate Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vonoprazan Fumarate
10.3 Manufacturing Process Analysis of Vonoprazan Fumarate
10.4 Industry Chain Structure of Vonoprazan Fumarate
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vonoprazan Fumarate Distributors
11.3 Vonoprazan Fumarate Customer
12 WORLD FORECAST REVIEW FOR VONOPRAZAN FUMARATE BY GEOGRAPHIC REGION
12.1 Global Vonoprazan Fumarate Market Size Forecast by Region
12.1.1 Global Vonoprazan Fumarate Forecast by Region (2027-2032)
12.1.2 Global Vonoprazan Fumarate Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Vonoprazan Fumarate Forecast by Type (2027-2032)
12.7 Global Vonoprazan Fumarate Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Takeda Pharmaceuticals
13.1.1 Takeda Pharmaceuticals Company Information
13.1.2 Takeda Pharmaceuticals Vonoprazan Fumarate Product Portfolios and Specifications
13.1.3 Takeda Pharmaceuticals Vonoprazan Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Takeda Pharmaceuticals Main Business Overview
13.1.5 Takeda Pharmaceuticals Latest Developments
13.2 Shandong New Era Pharmaceutical
13.2.1 Shandong New Era Pharmaceutical Company Information
13.2.2 Shandong New Era Pharmaceutical Vonoprazan Fumarate Product Portfolios and Specifications
13.2.3 Shandong New Era Pharmaceutical Vonoprazan Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Shandong New Era Pharmaceutical Main Business Overview
13.2.5 Shandong New Era Pharmaceutical Latest Developments
13.3 Chongqing Huasen Pharmaceutical
13.3.1 Chongqing Huasen Pharmaceutical Company Information
13.3.2 Chongqing Huasen Pharmaceutical Vonoprazan Fumarate Product Portfolios and Specifications
13.3.3 Chongqing Huasen Pharmaceutical Vonoprazan Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Chongqing Huasen Pharmaceutical Main Business Overview
13.3.5 Chongqing Huasen Pharmaceutical Latest Developments
13.4 Sichuan Kelun Pharmaceutical
13.4.1 Sichuan Kelun Pharmaceutical Company Information
13.4.2 Sichuan Kelun Pharmaceutical Vonoprazan Fumarate Product Portfolios and Specifications
13.4.3 Sichuan Kelun Pharmaceutical Vonoprazan Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sichuan Kelun Pharmaceutical Main Business Overview
13.4.5 Sichuan Kelun Pharmaceutical Latest Developments
13.5 Yangzijiang Pharmaceutical
13.5.1 Yangzijiang Pharmaceutical Company Information
13.5.2 Yangzijiang Pharmaceutical Vonoprazan Fumarate Product Portfolios and Specifications
13.5.3 Yangzijiang Pharmaceutical Vonoprazan Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Yangzijiang Pharmaceutical Main Business Overview
13.5.5 Yangzijiang Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Vonoprazan Fumarate Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Vonoprazan Fumarate Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 10mg Tablets
Table 4. Major Players of 20mg Tablets
Table 5. Global Vonoprazan Fumarate Sales by Type (2021-2026) & (K Units)
Table 6. Global Vonoprazan Fumarate Sales Market Share by Type (2021-2026)
Table 7. Global Vonoprazan Fumarate Revenue by Type (2021-2026) & ($ million)
Table 8. Global Vonoprazan Fumarate Revenue Market Share by Type (2021-2026)
Table 9. Global Vonoprazan Fumarate Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Vonoprazan Fumarate Sale by Application (2021-2026) & (K Units)
Table 11. Global Vonoprazan Fumarate Sale Market Share by Application (2021-2026)
Table 12. Global Vonoprazan Fumarate Revenue by Application (2021-2026) & ($ million)
Table 13. Global Vonoprazan Fumarate Revenue Market Share by Application (2021-2026)
Table 14. Global Vonoprazan Fumarate Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Vonoprazan Fumarate Sales by Company (2021-2026) & (K Units)
Table 16. Global Vonoprazan Fumarate Sales Market Share by Company (2021-2026)
Table 17. Global Vonoprazan Fumarate Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Vonoprazan Fumarate Revenue Market Share by Company (2021-2026)
Table 19. Global Vonoprazan Fumarate Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Vonoprazan Fumarate Producing Area Distribution and Sales Area
Table 21. Players Vonoprazan Fumarate Products Offered
Table 22. Vonoprazan Fumarate Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Vonoprazan Fumarate Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Vonoprazan Fumarate Sales Market Share Geographic Region (2021-2026)
Table 27. Global Vonoprazan Fumarate Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Vonoprazan Fumarate Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Vonoprazan Fumarate Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Vonoprazan Fumarate Sales Market Share by Country/Region (2021-2026)
Table 31. Global Vonoprazan Fumarate Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Vonoprazan Fumarate Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Vonoprazan Fumarate Sales by Country (2021-2026) & (K Units)
Table 34. Americas Vonoprazan Fumarate Sales Market Share by Country (2021-2026)
Table 35. Americas Vonoprazan Fumarate Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Vonoprazan Fumarate Sales by Type (2021-2026) & (K Units)
Table 37. Americas Vonoprazan Fumarate Sales by Application (2021-2026) & (K Units)
Table 38. APAC Vonoprazan Fumarate Sales by Region (2021-2026) & (K Units)
Table 39. APAC Vonoprazan Fumarate Sales Market Share by Region (2021-2026)
Table 40. APAC Vonoprazan Fumarate Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Vonoprazan Fumarate Sales by Type (2021-2026) & (K Units)
Table 42. APAC Vonoprazan Fumarate Sales by Application (2021-2026) & (K Units)
Table 43. Europe Vonoprazan Fumarate Sales by Country (2021-2026) & (K Units)
Table 44. Europe Vonoprazan Fumarate Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Vonoprazan Fumarate Sales by Type (2021-2026) & (K Units)
Table 46. Europe Vonoprazan Fumarate Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Vonoprazan Fumarate Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Vonoprazan Fumarate Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Vonoprazan Fumarate Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Vonoprazan Fumarate Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Vonoprazan Fumarate
Table 52. Key Market Challenges & Risks of Vonoprazan Fumarate
Table 53. Key Industry Trends of Vonoprazan Fumarate
Table 54. Vonoprazan Fumarate Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Vonoprazan Fumarate Distributors List
Table 57. Vonoprazan Fumarate Customer List
Table 58. Global Vonoprazan Fumarate Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Vonoprazan Fumarate Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Vonoprazan Fumarate Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Vonoprazan Fumarate Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Vonoprazan Fumarate Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Vonoprazan Fumarate Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Vonoprazan Fumarate Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Vonoprazan Fumarate Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Vonoprazan Fumarate Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Vonoprazan Fumarate Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Vonoprazan Fumarate Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Vonoprazan Fumarate Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Vonoprazan Fumarate Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Vonoprazan Fumarate Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Takeda Pharmaceuticals Basic Information, Vonoprazan Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 73. Takeda Pharmaceuticals Vonoprazan Fumarate Product Portfolios and Specifications
Table 74. Takeda Pharmaceuticals Vonoprazan Fumarate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Takeda Pharmaceuticals Main Business
Table 76. Takeda Pharmaceuticals Latest Developments
Table 77. Shandong New Era Pharmaceutical Basic Information, Vonoprazan Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 78. Shandong New Era Pharmaceutical Vonoprazan Fumarate Product Portfolios and Specifications
Table 79. Shandong New Era Pharmaceutical Vonoprazan Fumarate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Shandong New Era Pharmaceutical Main Business
Table 81. Shandong New Era Pharmaceutical Latest Developments
Table 82. Chongqing Huasen Pharmaceutical Basic Information, Vonoprazan Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 83. Chongqing Huasen Pharmaceutical Vonoprazan Fumarate Product Portfolios and Specifications
Table 84. Chongqing Huasen Pharmaceutical Vonoprazan Fumarate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Chongqing Huasen Pharmaceutical Main Business
Table 86. Chongqing Huasen Pharmaceutical Latest Developments
Table 87. Sichuan Kelun Pharmaceutical Basic Information, Vonoprazan Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 88. Sichuan Kelun Pharmaceutical Vonoprazan Fumarate Product Portfolios and Specifications
Table 89. Sichuan Kelun Pharmaceutical Vonoprazan Fumarate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Sichuan Kelun Pharmaceutical Main Business
Table 91. Sichuan Kelun Pharmaceutical Latest Developments
Table 92. Yangzijiang Pharmaceutical Basic Information, Vonoprazan Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 93. Yangzijiang Pharmaceutical Vonoprazan Fumarate Product Portfolios and Specifications
Table 94. Yangzijiang Pharmaceutical Vonoprazan Fumarate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Yangzijiang Pharmaceutical Main Business
Table 96. Yangzijiang Pharmaceutical Latest Developments
Table 1. Vonoprazan Fumarate Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Vonoprazan Fumarate Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 10mg Tablets
Table 4. Major Players of 20mg Tablets
Table 5. Global Vonoprazan Fumarate Sales by Type (2021-2026) & (K Units)
Table 6. Global Vonoprazan Fumarate Sales Market Share by Type (2021-2026)
Table 7. Global Vonoprazan Fumarate Revenue by Type (2021-2026) & ($ million)
Table 8. Global Vonoprazan Fumarate Revenue Market Share by Type (2021-2026)
Table 9. Global Vonoprazan Fumarate Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Vonoprazan Fumarate Sale by Application (2021-2026) & (K Units)
Table 11. Global Vonoprazan Fumarate Sale Market Share by Application (2021-2026)
Table 12. Global Vonoprazan Fumarate Revenue by Application (2021-2026) & ($ million)
Table 13. Global Vonoprazan Fumarate Revenue Market Share by Application (2021-2026)
Table 14. Global Vonoprazan Fumarate Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Vonoprazan Fumarate Sales by Company (2021-2026) & (K Units)
Table 16. Global Vonoprazan Fumarate Sales Market Share by Company (2021-2026)
Table 17. Global Vonoprazan Fumarate Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Vonoprazan Fumarate Revenue Market Share by Company (2021-2026)
Table 19. Global Vonoprazan Fumarate Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Vonoprazan Fumarate Producing Area Distribution and Sales Area
Table 21. Players Vonoprazan Fumarate Products Offered
Table 22. Vonoprazan Fumarate Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Vonoprazan Fumarate Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Vonoprazan Fumarate Sales Market Share Geographic Region (2021-2026)
Table 27. Global Vonoprazan Fumarate Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Vonoprazan Fumarate Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Vonoprazan Fumarate Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Vonoprazan Fumarate Sales Market Share by Country/Region (2021-2026)
Table 31. Global Vonoprazan Fumarate Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Vonoprazan Fumarate Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Vonoprazan Fumarate Sales by Country (2021-2026) & (K Units)
Table 34. Americas Vonoprazan Fumarate Sales Market Share by Country (2021-2026)
Table 35. Americas Vonoprazan Fumarate Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Vonoprazan Fumarate Sales by Type (2021-2026) & (K Units)
Table 37. Americas Vonoprazan Fumarate Sales by Application (2021-2026) & (K Units)
Table 38. APAC Vonoprazan Fumarate Sales by Region (2021-2026) & (K Units)
Table 39. APAC Vonoprazan Fumarate Sales Market Share by Region (2021-2026)
Table 40. APAC Vonoprazan Fumarate Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Vonoprazan Fumarate Sales by Type (2021-2026) & (K Units)
Table 42. APAC Vonoprazan Fumarate Sales by Application (2021-2026) & (K Units)
Table 43. Europe Vonoprazan Fumarate Sales by Country (2021-2026) & (K Units)
Table 44. Europe Vonoprazan Fumarate Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Vonoprazan Fumarate Sales by Type (2021-2026) & (K Units)
Table 46. Europe Vonoprazan Fumarate Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Vonoprazan Fumarate Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Vonoprazan Fumarate Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Vonoprazan Fumarate Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Vonoprazan Fumarate Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Vonoprazan Fumarate
Table 52. Key Market Challenges & Risks of Vonoprazan Fumarate
Table 53. Key Industry Trends of Vonoprazan Fumarate
Table 54. Vonoprazan Fumarate Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Vonoprazan Fumarate Distributors List
Table 57. Vonoprazan Fumarate Customer List
Table 58. Global Vonoprazan Fumarate Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Vonoprazan Fumarate Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Vonoprazan Fumarate Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Vonoprazan Fumarate Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Vonoprazan Fumarate Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Vonoprazan Fumarate Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Vonoprazan Fumarate Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Vonoprazan Fumarate Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Vonoprazan Fumarate Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Vonoprazan Fumarate Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Vonoprazan Fumarate Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Vonoprazan Fumarate Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Vonoprazan Fumarate Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Vonoprazan Fumarate Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Takeda Pharmaceuticals Basic Information, Vonoprazan Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 73. Takeda Pharmaceuticals Vonoprazan Fumarate Product Portfolios and Specifications
Table 74. Takeda Pharmaceuticals Vonoprazan Fumarate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Takeda Pharmaceuticals Main Business
Table 76. Takeda Pharmaceuticals Latest Developments
Table 77. Shandong New Era Pharmaceutical Basic Information, Vonoprazan Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 78. Shandong New Era Pharmaceutical Vonoprazan Fumarate Product Portfolios and Specifications
Table 79. Shandong New Era Pharmaceutical Vonoprazan Fumarate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Shandong New Era Pharmaceutical Main Business
Table 81. Shandong New Era Pharmaceutical Latest Developments
Table 82. Chongqing Huasen Pharmaceutical Basic Information, Vonoprazan Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 83. Chongqing Huasen Pharmaceutical Vonoprazan Fumarate Product Portfolios and Specifications
Table 84. Chongqing Huasen Pharmaceutical Vonoprazan Fumarate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Chongqing Huasen Pharmaceutical Main Business
Table 86. Chongqing Huasen Pharmaceutical Latest Developments
Table 87. Sichuan Kelun Pharmaceutical Basic Information, Vonoprazan Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 88. Sichuan Kelun Pharmaceutical Vonoprazan Fumarate Product Portfolios and Specifications
Table 89. Sichuan Kelun Pharmaceutical Vonoprazan Fumarate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Sichuan Kelun Pharmaceutical Main Business
Table 91. Sichuan Kelun Pharmaceutical Latest Developments
Table 92. Yangzijiang Pharmaceutical Basic Information, Vonoprazan Fumarate Manufacturing Base, Sales Area and Its Competitors
Table 93. Yangzijiang Pharmaceutical Vonoprazan Fumarate Product Portfolios and Specifications
Table 94. Yangzijiang Pharmaceutical Vonoprazan Fumarate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Yangzijiang Pharmaceutical Main Business
Table 96. Yangzijiang Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Vonoprazan Fumarate
Figure 2. Vonoprazan Fumarate Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vonoprazan Fumarate Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Vonoprazan Fumarate Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Vonoprazan Fumarate Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Vonoprazan Fumarate Sales Market Share by Country/Region (2025)
Figure 10. Vonoprazan Fumarate Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 10mg Tablets
Figure 12. Product Picture of 20mg Tablets
Figure 13. Global Vonoprazan Fumarate Sales Market Share by Type in 2026
Figure 14. Global Vonoprazan Fumarate Revenue Market Share by Type (2021-2026)
Figure 15. Vonoprazan Fumarate Consumed in Hospital and Clinic
Figure 16. Global Vonoprazan Fumarate Market: Hospital and Clinic (2021-2026) & (K Units)
Figure 17. Vonoprazan Fumarate Consumed in Retail Pharmacies
Figure 18. Global Vonoprazan Fumarate Market: Retail Pharmacies (2021-2026) & (K Units)
Figure 19. Vonoprazan Fumarate Consumed in Other
Figure 20. Global Vonoprazan Fumarate Market: Other (2021-2026) & (K Units)
Figure 21. Global Vonoprazan Fumarate Sale Market Share by Application (2025)
Figure 22. Global Vonoprazan Fumarate Revenue Market Share by Application in 2026
Figure 23. Vonoprazan Fumarate Sales by Company in 2026 (K Units)
Figure 24. Global Vonoprazan Fumarate Sales Market Share by Company in 2026
Figure 25. Vonoprazan Fumarate Revenue by Company in 2026 ($ millions)
Figure 26. Global Vonoprazan Fumarate Revenue Market Share by Company in 2026
Figure 27. Global Vonoprazan Fumarate Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Vonoprazan Fumarate Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Vonoprazan Fumarate Sales 2021-2026 (K Units)
Figure 30. Americas Vonoprazan Fumarate Revenue 2021-2026 ($ millions)
Figure 31. APAC Vonoprazan Fumarate Sales 2021-2026 (K Units)
Figure 32. APAC Vonoprazan Fumarate Revenue 2021-2026 ($ millions)
Figure 33. Europe Vonoprazan Fumarate Sales 2021-2026 (K Units)
Figure 34. Europe Vonoprazan Fumarate Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Vonoprazan Fumarate Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Vonoprazan Fumarate Revenue 2021-2026 ($ millions)
Figure 37. Americas Vonoprazan Fumarate Sales Market Share by Country in 2026
Figure 38. Americas Vonoprazan Fumarate Revenue Market Share by Country (2021-2026)
Figure 39. Americas Vonoprazan Fumarate Sales Market Share by Type (2021-2026)
Figure 40. Americas Vonoprazan Fumarate Sales Market Share by Application (2021-2026)
Figure 41. United States Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Vonoprazan Fumarate Sales Market Share by Region in 2026
Figure 46. APAC Vonoprazan Fumarate Revenue Market Share by Region (2021-2026)
Figure 47. APAC Vonoprazan Fumarate Sales Market Share by Type (2021-2026)
Figure 48. APAC Vonoprazan Fumarate Sales Market Share by Application (2021-2026)
Figure 49. China Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 53. India Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Vonoprazan Fumarate Sales Market Share by Country in 2026
Figure 57. Europe Vonoprazan Fumarate Revenue Market Share by Country (2021-2026)
Figure 58. Europe Vonoprazan Fumarate Sales Market Share by Type (2021-2026)
Figure 59. Europe Vonoprazan Fumarate Sales Market Share by Application (2021-2026)
Figure 60. Germany Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 61. France Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Vonoprazan Fumarate Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Vonoprazan Fumarate Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Vonoprazan Fumarate Sales Market Share by Application (2021-2026)
Figure 68. Egypt Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Vonoprazan Fumarate in 2026
Figure 74. Manufacturing Process Analysis of Vonoprazan Fumarate
Figure 75. Industry Chain Structure of Vonoprazan Fumarate
Figure 76. Channels of Distribution
Figure 77. Global Vonoprazan Fumarate Sales Market Forecast by Region (2027-2032)
Figure 78. Global Vonoprazan Fumarate Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Vonoprazan Fumarate Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Vonoprazan Fumarate Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Vonoprazan Fumarate Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Vonoprazan Fumarate Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Vonoprazan Fumarate
Figure 2. Vonoprazan Fumarate Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vonoprazan Fumarate Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Vonoprazan Fumarate Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Vonoprazan Fumarate Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Vonoprazan Fumarate Sales Market Share by Country/Region (2025)
Figure 10. Vonoprazan Fumarate Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 10mg Tablets
Figure 12. Product Picture of 20mg Tablets
Figure 13. Global Vonoprazan Fumarate Sales Market Share by Type in 2026
Figure 14. Global Vonoprazan Fumarate Revenue Market Share by Type (2021-2026)
Figure 15. Vonoprazan Fumarate Consumed in Hospital and Clinic
Figure 16. Global Vonoprazan Fumarate Market: Hospital and Clinic (2021-2026) & (K Units)
Figure 17. Vonoprazan Fumarate Consumed in Retail Pharmacies
Figure 18. Global Vonoprazan Fumarate Market: Retail Pharmacies (2021-2026) & (K Units)
Figure 19. Vonoprazan Fumarate Consumed in Other
Figure 20. Global Vonoprazan Fumarate Market: Other (2021-2026) & (K Units)
Figure 21. Global Vonoprazan Fumarate Sale Market Share by Application (2025)
Figure 22. Global Vonoprazan Fumarate Revenue Market Share by Application in 2026
Figure 23. Vonoprazan Fumarate Sales by Company in 2026 (K Units)
Figure 24. Global Vonoprazan Fumarate Sales Market Share by Company in 2026
Figure 25. Vonoprazan Fumarate Revenue by Company in 2026 ($ millions)
Figure 26. Global Vonoprazan Fumarate Revenue Market Share by Company in 2026
Figure 27. Global Vonoprazan Fumarate Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Vonoprazan Fumarate Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Vonoprazan Fumarate Sales 2021-2026 (K Units)
Figure 30. Americas Vonoprazan Fumarate Revenue 2021-2026 ($ millions)
Figure 31. APAC Vonoprazan Fumarate Sales 2021-2026 (K Units)
Figure 32. APAC Vonoprazan Fumarate Revenue 2021-2026 ($ millions)
Figure 33. Europe Vonoprazan Fumarate Sales 2021-2026 (K Units)
Figure 34. Europe Vonoprazan Fumarate Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Vonoprazan Fumarate Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Vonoprazan Fumarate Revenue 2021-2026 ($ millions)
Figure 37. Americas Vonoprazan Fumarate Sales Market Share by Country in 2026
Figure 38. Americas Vonoprazan Fumarate Revenue Market Share by Country (2021-2026)
Figure 39. Americas Vonoprazan Fumarate Sales Market Share by Type (2021-2026)
Figure 40. Americas Vonoprazan Fumarate Sales Market Share by Application (2021-2026)
Figure 41. United States Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Vonoprazan Fumarate Sales Market Share by Region in 2026
Figure 46. APAC Vonoprazan Fumarate Revenue Market Share by Region (2021-2026)
Figure 47. APAC Vonoprazan Fumarate Sales Market Share by Type (2021-2026)
Figure 48. APAC Vonoprazan Fumarate Sales Market Share by Application (2021-2026)
Figure 49. China Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 53. India Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Vonoprazan Fumarate Sales Market Share by Country in 2026
Figure 57. Europe Vonoprazan Fumarate Revenue Market Share by Country (2021-2026)
Figure 58. Europe Vonoprazan Fumarate Sales Market Share by Type (2021-2026)
Figure 59. Europe Vonoprazan Fumarate Sales Market Share by Application (2021-2026)
Figure 60. Germany Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 61. France Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Vonoprazan Fumarate Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Vonoprazan Fumarate Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Vonoprazan Fumarate Sales Market Share by Application (2021-2026)
Figure 68. Egypt Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Vonoprazan Fumarate Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Vonoprazan Fumarate in 2026
Figure 74. Manufacturing Process Analysis of Vonoprazan Fumarate
Figure 75. Industry Chain Structure of Vonoprazan Fumarate
Figure 76. Channels of Distribution
Figure 77. Global Vonoprazan Fumarate Sales Market Forecast by Region (2027-2032)
Figure 78. Global Vonoprazan Fumarate Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Vonoprazan Fumarate Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Vonoprazan Fumarate Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Vonoprazan Fumarate Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Vonoprazan Fumarate Revenue Market Share Forecast by Application (2027-2032)
